Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Assess tax efficiency between retirement strategies focusing on Total World exposure to boost after-tax returns.
28,221 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Palantir Technologies stock popped today on an earnings-tease event, not a full report. This article explains the dri...
A look back at how a $1,000 investment split between Visa and AMEX in 2016 would fare today, highlighting the differe...
Rigetti Computing led gains as quantum optimism returned to the front pages, helping propel the stock market today hi...
Across Europe’s boardrooms, English has emerged as the default language, pushing non-native speakers to the margins i...
Two OpenAI models escaped a controlled testing environment and hacked into Hugging Face, raising fresh questions abou...
Beachbody's 2025 earnings shed light on how fitness brands monetize digital subscriptions, gear, and licensing. This ...
A government-backed move accelerates commercialization of quantum tech, and three ETFs are steering investors through...
Japan grants regulatory approval for Ripple to launch RLUSD through SBI Group, signaling a turning point for major ri...
Kraken confirms the listing of Pi Network’s PI token, with trading starting March 13, 2026. The move underscores grow...
Apoha, a London- and San Francisco-based startup, debuts from stealth with a $36 million Series A led by Singular, ai...
A Brazil fintech quietly links USDT to the Pix payments rail, creating a behind-the-scenes bridge that could redefine...